Yazar "Trabzon, Gul" seçeneğine göre listele
Listeleniyor 1 - 3 / 3
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe N95 mask usage in children with type 1 diabetes mellitus: Does it affect clinical outcomes?(Elsevier Science Inc, 2025) Trabzon, Gul; Gullu, Seyma Demiray; Gungor, Sukru; Caliskan, Osman Firat; Oguzman, Hamdi; Ozcan, Oguzhan; Gullu, Ufuk UtkuBackground: The global COVID-19 pandemic has necessitated the widespread use of N95 masks, yet their impact on children with chronic conditions like type 1 diabetes (T1DM) remains underexplored. Objective: This study investigates the effects of N95 mask usage on clinical outcomes in children with T1DM. Methods: This study enrolled 34 children aged 10-18 with T1DM. Study participants' systemic symptoms and physiological parameters were assessed before and after wearing N95 masks for one hour. Blood glucose levels and capillary blood gas analyses were performed, and any symptoms reported were documented. Results: Nearly half of the participants (47 %) experienced symptoms such as difficulty breathing (41.2 %), ear pain (26.5 %), and runny nose (20.6 %). Despite these symptoms, no significant changes were observed in laboratory values or vital signs, including blood glucose levels, pH, pCO2, HCO3, base excess, lactate, blood pressure, respiratory rate, pulse rate, and oxygen saturation. Conclusions: The findings suggest that N95 masks may cause discomfort but do not adversely affect physiological parameters in children with T1DM. The study highlights the importance of balancing mask-related discomfort with the protective benefits of mask usage in this population. To confirm these findings, more extensive studies with extended mask use durations are needed. Practice implications: Nurses are crucial in educating children and their families about proper mask usage, addressing potential discomfort, and implementing strategies to improve adherence. These may include ensuring an appropriate mask fit and advising on brief, safe breaks when needed. (c) 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.Öğe The Effect of Continuous Glucose Monitoring Device Assistance on Glycaemic Control in Children and Adolescents with Type 1 Diabetes Following the 2023 Turkiye Earthquake Doublet: A Multicentre Study(Karger, 2024) Tarcin, Gurkan; Atas, Nurgul; Cay, Mevra; Sahin, Kadriye Cansu; Trabzon, Gul; Dundar, Ismail; Cicek, Dilek[No abstract available]Öğe The impact of hepatic steatosis on epicardial adipose tissue in obese individuals(Walter De Gruyter Gmbh, 2026) Trabzon, Gul; Ozturk Keles, Fatma; Caliskan, Osman Firat; Gungor, Sukru; Yarar, Nuriye; Gullu, Ufuk UtkuObjectives This study aimed to evaluate the relationship between epicardial adipose tissue (EAT) thickness and hepatic steatosis in pediatric patients with obesity, exploring EAT as a potential biomarker for cardiovascular risk. Methods A retrospective analysis was conducted on children with obesity aged 10-18, including 48 patients with NAFLD and 50 age- and sex-matched controls with no liver steatosis. EAT thickness was measured using echocardiography, and liver fat was assessed via ultrasound. Correlations between EAT, metabolic parameters, and anthropometric measurements were examined. Results EAT thickness was significantly more excellent in the NAFLD group than in controls (p<0.001), with an optimal cutoff of >1.6 mm predicting hepatic steatosis with 98 % sensitivity and specificity. Positive correlations were found between EAT thickness, body mass index (BMI) Z-scores, and liver steatosis stages. Additionally, structural cardiac changes, such as increased RVDD and IVSd, were observed in the NAFLD group, suggesting early signs of cardiac remodeling. Conclusions EAT thickness may be a non-invasive biomarker for identifying cardiovascular risk in pediatric patients with obesity and NAFLD. Early detection of elevated EAT could guide interventions to reduce obesity-related cardiovascular risk in this population.
